IV

Invesco Ltd.

IVZFinancial ServicesNASDAQ

Asset Management · Last scanned Jul 17, 2026

PriceMA150MA200
Loading chart…
End-of-day data · ScananceOpen live chart on TradingView ↗
Indicator snapshot · Today
Premium
Today's indicator reading is locked

Free plan shows historical signals only. Upgrade to see this ticker's current MA150, MA200, RSI, and MACD readings.

Upgrade to see today →
Financials · Annual
Revenue
$6.38B
+5.1% YoY
Net Income
-$281.7M
-136.4% YoY
EBITDA
$1.54B
+23.5% YoY
Free Cash Flow
$861.9M

Scan Results

Daily timeframe
8 recent days hidden. Fresh signals are a Premium featureUpgrade →
DateIndicatorDetails
Jul 11 MACD Positive CrossoverHistogram +0.1527, positive momentum
Jul 10 MACD Positive CrossoverHistogram +0.0653, positive momentum
About Invesco Ltd.

Invesco Ltd. is a publicly owned investment manager. Valued at $13.43B, IVZ is a large-cap name in its sector. The firm provides its services to retail clients, institutional clients, high-net worth clients, public entities, corporations, unions, non-profit organizations, endowments, foundations, pension funds, financial institutions, and sovereign wealth funds.

Key stats
Market Cap$13.43B
Fwd P/E9.48
EPS$-1.47
Beta1.60
52W Change+75.3%
Dividend Yield2.84%
ROE-1.5%
Analysis

The company holds $806.9M in cash, though total debt stands at $1.97B. This level of leverage is common in the industry but worth monitoring as interest rate conditions evolve. The company generates $861.9M in free cash flow annually, which funds everything from R&D to shareholder returns without needing external financing. Return on equity stands at -1.5%, which is negative for the sector. ROE measures how effectively a company uses shareholder capital to generate profits. ROA of 2.7% is on the lower side, which is common in asset-heavy industries. Revenue has been relatively flat, moving from $6.05B (2022) to $6.38B (2025).

Invesco Ltd.'s elevated beta suggests the stock experiences more pronounced price movements than the overall market, which increases both upside potential and downside risk. No single metric tells the full story. Reviewing IVZ's risk profile alongside its fundamentals and technical indicators provides a more complete picture.

Links
More Financial Services stocks
Browse all stocks →
Not financial advice. Scanance is an educational tool. Past performance does not guarantee future results.PrivacyTerms